West Pharmaceutical Services (WST) Shares Outstanding (Diluted Average) (2009 - 2026)

West Pharmaceutical Services has disclosed Shares Outstanding (Diluted Average) across 17 years of filings, most recently posting $72.4 million for Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $72.4 million, down 0.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $72.4 million (down 0.82% YoY), and the FY2025 annual result was $72.7 million, down 1.36% from the prior year.
• Shares Outstanding (Diluted Average) came in at $72.4 million for Q1 2026 at West Pharmaceutical Services, roughly flat from $72.7 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $76.0 million in Q1 2022 to a low of $72.4 million in Q1 2026.
• The 5-year median for Shares Outstanding (Diluted Average) is $74.3 million (2024), against an average of $74.3 million.
• Across the five-year window, Shares Outstanding (Diluted Average) advanced 0.26% in 2022 and fell 2.52% in 2024, its largest moves.
• West Pharmaceutical Services' Shares Outstanding (Diluted Average) stood at $75.8 million in 2022, then slipped by 0.66% to $75.3 million in 2023, then dropped by 2.12% to $73.7 million in 2024, then decreased by 1.36% to $72.7 million in 2025, then retreated by 0.41% to $72.4 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $72.4 million (Q1 2026), $72.7 million (Q4 2025), and $72.6 million (Q3 2025), per Business Quant data.